Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2021, NOVEL THERAPEUTIC AGENTS
Domínguez-Jurado E, Cimas FJ, Castro-Osma JA, Juan A, Lara-Sánchez A, Rodríguez-Diéguez A, Shafir A, Ocaña A, Alonso-Moreno CPharmaceutics. 2021 Sep...
JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NANOMEDICINES, REVIEWS
Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles Juan A, Del Mar Noblejas-López M, Arenas-Moreira M, Alonso-Moreno C, Ocaña A. Front Cell Dev Biol. 2022 Feb 3;9:805336. PMID: 35186955; PMCID: PMC8851355 doi:...
Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS
Nieto-Jiménez C, Morafraile EC, Alonso-Moreno C, Ocaña A. Mol Cancer. 2022 Mar 7;21(1):67. PMID: 35249548; PMCID: PMC8900451....
Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS
Ocaña AV, Aguilera-Correa JJ, Domínguez-Jurado E, Pérez-Martínez FC, Pérez-Tanoira R, López-Carretero Y, Masiá-Mondejar J, Castro-Osma JA, Esteban J, Alonso-Moreno C, Molina-Alarcón M, Seguí P. Laryngoscope Investig Otolaryngol. 2022 Jan 18;7(1):283-290. doi:...
JOURNAL ARTICLES 2019, NOVEL THERAPEUTIC AGENTS
Screening and Preliminary Biochemical and Biological Studies of [RuCl(p-cymene)(N, N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models Corrales Sánchez V, Nieto-Jiménez C, Castro-Osma JA, de Andrés F, Pacheco-Liñán PJ, Bravo I, Rodríguez Fariñas...
